KalVista Pharmaceuticals, Inc. ($KALV)
Venrock Healthcare Capital Partners III, L.P. โ 10% Owner
Shares
160
Price
$17.53
Total Value
$2,804.80
Nearby Earnings
Mar 24, 2026
EPS:Est: -0.54
Revenue:Est: $32.29M
Mar 25, 2026
EPS:Est: -0.53
Revenue:Est: $32.29M
Transaction Details
| Insider | Venrock Healthcare Capital Partners III, L.P. |
|---|---|
| Title | 10% Owner |
| Transaction Date | Mar 25, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Indirect |
| Nature of Ownership | By Funds |
| Filing Date | Mar 27, 2026 |
| Shares Sold | 160 |
| Price per Share | $17.53 |
| Total Value | $2,804.80 |
| Shares Owned After | 5,129,340 |
| Derivative | No |
| Accession Number | 0001231919-26-000286 |
| Document | View SEC Filing |